Close Menu

NEW YORK (GenomeWeb) – Precision System Science recently announced a business alliance with Hitachi High-Technologies that it said will "enable the firm to further strengthen its business platform as an innovative biotechnology company."

Under the terms of the deal, PSS will supply to Hitachi its nucleic acid isolation system, fully automated diagnostic instruments, and reagents. In return, Hitachi will provide to PSS technology, production, sales network, and manpower.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Biden Administration is investing $1.7 billion to detect and monitor SARS-CoV-2 variants.

Italy has held talks with vaccine developers to manufacture mRNA-based SARS-CoV-2 vaccines, according to the Financial Times.

The Associated Press reports US officials are removing restrictions on fetal tissue research that were added during the Trump Administration.

In PLOS this week: genome instability in Aicardi-Goutières Syndrome, introduction of SARS-CoV-2 to the Colombian Amazon, and more.